Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease.
Michael
M
Stadler
Renate
R
Ahlborn
Haytham
H
Kamal
Helmut
H
Diedrich
Stefanie
S
Buchholz
Matthias
M
Eder
Arnold
A
Ganser
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D055815:Young Adult; D001549:Benzamides; D002908:Chronic Disease; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000473:pathology; D000068877:Imatinib Mesylate; D008171:Lung Diseases / Q000150:complications / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation; D010865:Pilot Projects; D010879:Piperazines / Q000627:therapeutic use; D011446:Prospective Studies; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases; D011743:Pyrimidines / Q000627:therapeutic use; D016879:Salvage Therapy; D016896:Treatment Outcome; D002986:Clinical Trials as Topic
D001549:Benzamides; D000068877:Imatinib Mesylate; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases; D011743:Pyrimidines